Covington Kyle R, Fuqua Suzanne A W
Lester and Sue Smith Breast Center, One Baylor Plaza, Baylor College of Medicine, 1220 N. Alkek, MS: 600, Houston, TX, 77030, USA,
Cancer Metastasis Rev. 2014 Dec;33(4):921-8. doi: 10.1007/s10555-014-9518-0.
Metastasis is the ultimate cause of death for most cancer patients. While many mechanisms have been delineated for regulation of growth and tumor initiation of the primary tumor, very little is known about the process of metastasis. Metastasis requires dynamic alteration of cellular processes in order for cells to disseminate from the primary tumor to distant sites. These alterations often involve dramatic changes in the regulation of cytoskeletal and cell-environment interactions. Furthermore, controlled refinement of these interactions requires feedback to regulatory networks in the nucleus. MTA2 is a member of the metastasis tumor-associated family of transcriptional regulators and is a central component of the nucleosome remodeling and histone deacetylation complex. MTA2 acts as a central hub for cytoskeletal organization and transcription and provides a link between nuclear and cytoskeletal organization. We will focus on MTA2 in this chapter, especially its role in breast cancer metastasis.
转移是大多数癌症患者死亡的最终原因。虽然已经阐明了许多调节原发性肿瘤生长和起始的机制,但对于转移过程却知之甚少。转移需要细胞过程的动态改变,以便细胞从原发性肿瘤扩散到远处部位。这些改变通常涉及细胞骨架和细胞与环境相互作用调节的显著变化。此外,对这些相互作用的精确控制需要反馈到细胞核中的调节网络。MTA2是转移肿瘤相关转录调节因子家族的成员,是核小体重塑和组蛋白去乙酰化复合体的核心成分。MTA2作为细胞骨架组织和转录的中心枢纽,在细胞核和细胞骨架组织之间建立了联系。在本章中,我们将重点关注MTA2,尤其是其在乳腺癌转移中的作用。